Abstract: Features are disclosed for dynamically generating a proxy representation of characteristics associated with a private data set. A computing device can receive a private data set including private or proprietary information. The compute device can determine one or more characteristics that are associated with the private data set. The computing device can further receive a public data library that includes characteristics that are publicly available. The computing device may generate a proxy representation based on the public data library and the proxy representation may include one or more characteristics that represent the private data set. The proxy representation may be provided to one or more entities who are unauthorized to access the private data set. In some embodiments, the private data set may correspond to an exchange traded fund and the characteristics may correspond to risk factors associated with the exchange traded fund.

Abstract: Features are disclosed for dynamically generating a proxy representation of characteristics associated with a private data set. A computing device can receive a private data set including private or proprietary information. The compute device can determine one or more characteristics that are associated with the private data set. The computing device can further receive a public data library that includes characteristics that are publicly available. The computing device may generate a proxy representation based on the public data library and the proxy representation may include one or more characteristics that represent the private data set. The proxy representation may be provided to one or more entities who are unauthorized to access the private data set. In some embodiments, the private data set may correspond to an exchange traded fund and the characteristics may correspond to risk factors associated with the exchange traded fund.

Abstract: Generation of scripts that facilitate execution of tasks within different run-time environments that utilize different languages and syntax is provided herein. A system comprises a memory that stores executable components and a processor, operatively coupled to the memory, that executes the executable components. The executable components comprise an identification manager component that identifies one or more elements of input data. The input data can comprise test data that comprises respective identifications of an input variable, an output variable, a test vector comprising an initial value of a test input, and an expected output variable against which test results are compared. The executable components can also comprise a template tool component that generates output data that facilitates execution of tasks within different run-time environments that utilize different languages and syntax.

Abstract: Generation of scripts that facilitate execution of tasks within different run-time environments that utilize different languages and syntax is provided herein. A system comprises a memory that stores executable components and a processor, operatively coupled to the memory, that executes the executable components. The executable components comprise an identification manager component that identifies one or more elements of input data. The input data can comprise test data that comprises respective identifications of an input variable, an output variable, a test vector comprising an initial value of a test input, and an expected output variable against which test results are compared. The executable components can also comprise a template tool component that generates output data that facilitates execution of tasks within different run-time environments that utilize different languages and syntax.

Abstract: A composite yarn comprising one or more ultra-high molecular weight polyethylene fibers wrapped around one or more polyurethane-polyurea copolymer fibers.

Abstract: A composite yarn comprising one or more ultra-high molecular weight polyethylene fibres wrapped around one or more polyurethane-polyurea copolymer fibres.

Abstract: A system for use in processing cash transactions comprising an electronic processor and a database, the processor comprising an interface for receiving requests for generating coded numbers representing cash and receiving requests that numbers previously allocated may be redeemed, the interface including a message format storage area storing a plurality of prescribed message formats and determining by reference to the stored message formats the format of a received message, a holding memory for holding requests of specified message formats so that single requests for generating a plurality of numbers in a batch can be processed.

Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.

Abstract: A paper machine configured as a swing machine capable of producing both light and heavy grades providing a Yankee hood split into a wet end half and a dry end half, at least one hood half being a flex-hood half wherein the supply for that half is capable of being run with either combustion heat or recycled heat and is capable of either recirculating the exhaust from the hood or discharging it to the atmosphere. The heater for the flex-hood half comprises both a primary combustion heat source and an indirect heat source capable of extracting by-product heat from another operation. The exhaust system for the flex hood half is capable of being run in either a straight through mode or in a recirculating mode.

Abstract: The present invention relates to cosmetic and dermatological preparations for protecting human skin and hair against UV radiation, comprising surface-coated titanium dioxide particles which are transparent in the visible region and have a crystallite size of from 10 to 20 nm and a specific surface area of from 90 to 110 m2/g, wherein the surface coating of the titanium dioxide particles comprises a multicoating of a) aluminum oxide and b) methicone or a copolymer of methicone and dimethicone or a multicoating of a) aluminum oxide, b) methicone or a copolymer of methicone and dimethicone and c) silicon dioxide.

Abstract: The present invention relates to a recombinant polyepitope cytotoxic T lymphocyte vaccine. The vaccine comprises at least one recombinant protein including a plurality of cytotoxic T lymphocyte epitopes from one or more pathogens, wherein the at least one recombinant protein is substantially free of sequences naturally found to flank the cytotoxic T lymphocyte epitopes. In addition the present invention also provides a polynucleotide including at least one sequence encoding a plurality of cytotoxic T lymphocyte epitopes from one or more pathogens.

Abstract: A starter/generator system for a gas turbine engine used in aeronautical applications that couples a single dynamoelectric machine to the gas turbine engine through a torque converter in a starting mode, and engages the engine to the dynamoelectric machine through a mechanical differential in a generating mode after the engine reaches self-sustaining speed and combines the output of the engine and the torque converter to regulate the frequency of AC generated by the dynamoelectric machine within a range of frequencies suitable for on-board electrical equipment by dynamically regulating the flow of hydraulic fluid to the torque converter.

Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.

Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.

Abstract: A starter/generator system for a gas turbine engine used in aeronautical applications that couples a single dynamoelectric machine to the gas turbine engine through a torque converter in a starting mode, and engages the engine to the dynamoelectric machine through a mechanical differential in a generating mode after the engine reaches self-sustaining speed and combines the output of the engine and the torque converter to regulate the frequency of AC generated by the dynamoelectric machine within a range of frequencies suitable for on-board electrical equipment by dynamically regulating the flow of hydraulic fluid to the torque converter.

Abstract: A starter/generator system for a gas turbine engine used in aeronautical applications that couples a single dynamoelectric machine to the gas turbine engine through a torque converter in a starting mode, and then disengages the torque converter and engages the engine to the dynamoelectric machine through an adjustable speed transmission in a generating mode after the engine reaches self-sustaining speed, wherein the speed of the adjustable speed transmission is set to match the frequency of AC generated by the dynamoelectric machine with on-board electrical equipment requirements to suit flight conditions.

Abstract: An ortho-planar spring has a platform movably coupled to a base and being movable linearly with respect to the base along at least a portion of an axial direction perpendicular to both a base surface and a platform surface. A resilient and flexible connecting structure is connected to and between the base and platform. The connecting structure is bendable to develop (i) an axial force along the axial direction to bias the platform in a stable position with respect to the base, and (ii) non-axial forces which substantially sum to zero to preserve the orientation of the platform with respect to the base. Thus, the spring is very compact and does not have rotation between the deflecting ends. The spring may be associated with a valve opening, and a button for restricting flow through the valve opening, to bias the button at a position with respect to the valve opening.

Abstract: An electronic processor system for use in processing cash transactions comprising an electronic processor and a database, the processor comprising: i) an interface for receiving requests for generating coded numbers representing cash and receiving requests that numbers previously allocated may be redeemed, the interface including a message format storage area storing a plurality of prescribed message formats and determining by reference to the stored message formats the format of a received message, a holding memory for holding requests of specified message formats so that single requests for generating a plurality of numbers in a batch can be processed.

Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.

Abstract: Disclosed are pharmaceutical composition comprising a beta-blocker and an adenosine A1 receptor antagonist (AA1RA), an angiotensin converting enzyme (ACE) inhibitor and an adenosine A1 receptor antagonist (AA1RA), and an angiotensin II receptor blocker (ARB) and an adenosine A1 receptor antagonist (AA1RA). Also disclosed are methods of treating cardiovascular disease, renal disease, alkalosis, or diabetic nephropathy comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient.